CX3CR1 and bacterial arthritis: The released CGRP then inhibits the production of chemotactic cytokines by CX3CR1<sup>+</sup> tissue-resident synovial lining macrophages via receptor activity modifying protein 1 (RAMP1) receptors at the onset of septic arthritis.